Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Everolimus + Letrozole in ER+ Breast Cancer
NCT00107016Phase 2Completed
- Sponsor
- Novartis
- Start
- Mar 2005
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of everolimus in breast cancer, sponsored by Novartis. Started Mar 2005; status: completed.
02
Drugs
everolimus
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00107016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00107016.